Drugs / GW695634
last change Apr 2004 re-read 3 minutes ago

GW695634

Small molecule

Developed for
HIV infectious disease
Investigated by
GlaxoSmithKline

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00090077 Apr 2004 → ? HIV infectious disease GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as GW695634 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00090077 ↗
Modality Small molecule — CHEMBL1233182 ↗
Route Oral “Four Oral Dosage Regimens of GW695634G Monotherapy” NCT00090077 ↗